For: | Wu X, Wang L, Ye YZ, Yu H. Postoperative multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intravenous doxycycline and intraventricular gentamicin: A case report. World J Clin Cases 2019; 7(24): 4342-4348 [PMID: 31911917 DOI: 10.12998/wjcc.v7.i24.4342] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v7/i24/4342.htm |
Number | Citing Articles |
1 |
Maria Soledad Ramirez, Robert A. Bonomo, Marcelo E. Tolmasky. Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace. Biomolecules 2020; 10(5): 720 doi: 10.3390/biom10050720
|
2 |
Jiyan Xu, Xiaoling Du, Dan Li, Pei Li, Qinglan Guo, Xiaogang Xu, Fupin Hu, Minggui Wang. Clinical characteristics and antimicrobial therapy of healthcare-associated carbapenem-non-susceptible gram-negative bacterial meningitis: a 16-year retrospective cohort study. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09237-9
|
3 |
Wei Dou, Xin Liu, Pengjiao An, Wei Zuo, Bo Zhang. Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report. Expert Opinion on Drug Safety 2024; 23(7): 885 doi: 10.1080/14740338.2024.2359615
|
4 |
Prakhar Srivastava, Kwang-sun Kim. Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies. Pharmaceutics 2022; 14(11): 2370 doi: 10.3390/pharmaceutics14112370
|
5 |
Emilio Bouza, Patricia Muñoz, Almudena Burillo. How to treat severe Acinetobacter baumannii infections. Current Opinion in Infectious Diseases 2023; 36(6): 596 doi: 10.1097/QCO.0000000000000974
|